Radon and lung cancer: a cost-effectiveness analysis.

OBJECTIVES This study examined the cost-effectiveness of general and targeted strategies for residential radon testing and mitigation in the United States. METHODS A decision-tree model was used to perform a cost-effectiveness analysis of preventing radon-associated deaths from lung cancer. RESULTS For a radon threshold of 4 pCi/L, the estimated costs to prevent 1 lung cancer death are about $3 million (154 lung cancer deaths prevented), or $480,000 per life-year saved, based on universal radon screening and mitigation, and about $2 million (104 lung cancer deaths prevented), or $330,000 per life-year saved, if testing and mitigation are confined to geographic areas at high risk for radon exposure. For mitigation undertaken after a single screening test and after a second confirmatory test, the estimated costs are about $920,000 and $520,000, respectively, to prevent a lung cancer death with universal screening and $130,000 and $80,000 per life-year for high risk screening. The numbers of preventable lung cancer deaths are 811 and 527 for universal and targeted approaches, respectively. CONCLUSIONS These data suggest possible alternatives to current recommendations.

[1]  C. Eheman,et al.  Radon retesting and mitigation behavior among the U.S. population. , 1997, Health physics.

[2]  K E Warner,et al.  Toward a more realistic appraisal of the lung cancer risk from radon: the effects of residential mobility. , 1996, American journal of public health.

[3]  P. Franks,et al.  Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. , 1996, JAMA.

[4]  C. Eheman,et al.  Radon awareness and testing behavior: findings from the Behavioral Risk Factor Surveillance System, 1989-1992. , 1996, Health physics.

[5]  A. V. Nero,et al.  Joint Analysis of Long-and Short-term Radon Monitoring Data from the Northern U.S. , 1996 .

[6]  J H Lubin,et al.  Cigarette use and the estimation of lung cancer attributable to radon in the United States. , 1995, Radiation research.

[7]  H. Maillie,et al.  The influence of life table corrections for smokers and nonsmokers on the health effects of radon using the BEIR (biological effects of ioniziing radiation) IV method. , 1994, Health physics.

[8]  E. G. Letourneau,et al.  Cost Effectiveness of Radon Mitigation in Canada , 1992 .

[9]  D Ozonoff,et al.  Compliance with EPA guidelines for follow-up testing and mitigation after radon screening measurements. , 1992, Health physics.

[10]  S. Wozniak.  Lung cancer and radon. , 1992, BMJ.

[11]  T. Hodgson,et al.  Cigarette smoking and lifetime medical expenditures. , 1992, The Milbank quarterly.

[12]  Gary H. McClelland,et al.  Protective Responses to Household Risk A Case Study of Radon Mitigation , 1991 .

[13]  C. Bowie,et al.  Radon and health , 1991, The Lancet.

[14]  K. Mossman,et al.  Regulatory control of indoor Rn. , 1991, Health physics.

[15]  P. Abelson.  Uncertainties about health effects of radon , 1990, Science.

[16]  J. Samet,et al.  Review of radon and lung cancer risk. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[17]  J. Puskin,et al.  EPA's perspective on risks from residential radon exposure. , 1989, JAPCA.

[18]  G. Oster,et al.  The cost-effectiveness of counseling smokers to quit. , 1989, JAMA.

[19]  O. Castrén.  Strategies to Reduce Exposure to Indoor Radon , 1988 .

[20]  T. Hodgson,et al.  The economic costs of the health effects of smoking, 1984. , 1986, The Milbank quarterly.

[21]  G. Oster,et al.  Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. , 1986, JAMA.

[22]  D. Moeller,et al.  Cost evaluation of control measures for indoor radon progeny. , 1984, Health physics.

[23]  D. Bodansky,et al.  Indoor radon. , 1983, Health physics.

[24]  O. Axelson.  Aspects on confounding in occupational health epidemiology. , 1978, Scandinavian journal of work, environment & health.

[25]  R. Schoental.  ARE RAUWOLFIA ALKALOIDS CARCINOGENIC , 1974 .